The Latest Breaking News from MindBio rapeutics

In Psychedelic Investing, Long-Term Thinking Is Key

This article was originally published on Microdose and appears here with permission.  In response to a worldwide mental illness epidemic and flood of capital from investing firms, the psychedelic industry has seen explosive growth in recent years.

Benzinga · Aug 13, 2022

Blackhawk's Mindbio Therapeutics Announces Research Collaborators at University of Auckland Receive Grant Funding of $1.44 Million for LSD Microdosing Trials in Major Depressive Disorder

Successful grant comes after recent successful completion of Phase 1 LSD Microdosing LSD Trial in 80 participants 

Benzinga · Jul 30, 2022

Blackhawk Appoints Justin Hanka as Chairman of The Board

Vancouver, British Columbia – TheNewswire - June 06, 2022 – Blackhawk Growth Corp. (the "Company") (CSE:BLR) (OTC:BLRZF) (Frankfurt:0JJ) is pleased to announce  the appointment of investment banker Justin Hanka as Director and Chairman of the Board of Directors to help execute corporate transactions in Blackhawk.

Benzinga · Jun 11, 2022